• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌患者预后和免疫浸润的综合分析,寻找潜在的生存指标的关键基因。

An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.

机构信息

Department of Thoracic Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, 210000, China.

Department of Cardiothoracic Surgery, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, 223300, China.

出版信息

World J Surg Oncol. 2022 Mar 30;20(1):99. doi: 10.1186/s12957-022-02543-z.

DOI:10.1186/s12957-022-02543-z
PMID:35354488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8966338/
Abstract

OBJECTIVE

Lung adenocarcinoma (LUAD) is one of the major subtypes of lung cancer that is associated with poor prognosis. The aim of this study was to identify useful biomarkers to enhance the treatment and diagnosis of LUAD.

METHODS

GEO2R was used to identify common up-regulated differentially expressed genes (DEGs) in the GSE32863, GSE40791, and GSE75037 datasets. The DEGs were submitted to Metascape for gene ontology and pathway enrichment analysis as well as construction of the protein-protein interaction (PPI) network, while the molecular complex detection (MCODE) plug-in was employed to filter important subnetworks. The expression levels of the hub genes and their prognostic values were evaluated using the UALCAN, GEPIA2, and Kaplan-Meier plotter databases. The timer algorithm was utilized to determine the correlation between immune cell infiltration and the expression levels of hub genes in LUAD tissues. In addition, the hub gene mutation landscape and the correlation analysis with tumor mutational burden (TMB) score were evaluated using maftools package and ggstatsplot package in R software, respectively.

RESULTS

We identified 156 common up-regulated DEGs, with gene ontology and pathway enrichment analysis indicating that they were mostly enriched in mitotic cell cycle process and cell cycle pathway. DEGs in the subnetwork with the largest number of genes were AURKB, CCNB2, CDC20, CDCA5, CDCA8, CENPF, and KNTC1. The seven hub genes were highly expressed in LUAD tissues and were associated with poor prognosis. These hub genes were negatively correlated with most immune cells. The somatic mutation landscape showed that AURKB, CDC20, CENPF, and KNTC1 had mutations and were positively correlated with TMB scores.

CONCLUSIONS

Our findings demonstrate that increased expression of seven hub genes is associated with poor prognosis for LUAD patients. Additionally, the TMB score indicates that the high expression of hub gene increases immune cell infiltration in patients with lung adenocarcinoma which may significantly improve response to immunotherapy.

摘要

目的

肺腺癌(LUAD)是肺癌的主要亚型之一,与预后不良有关。本研究旨在鉴定有用的生物标志物,以增强 LUAD 的治疗和诊断。

方法

使用 GEO2R 鉴定 GSE32863、GSE40791 和 GSE75037 数据集之间常见的上调差异表达基因(DEG)。将 DEG 提交给 Metascape 进行基因本体论和途径富集分析以及构建蛋白质-蛋白质相互作用(PPI)网络,同时使用分子复合物检测(MCODE)插件筛选重要的子网络。使用 UALCAN、GEPIA2 和 Kaplan-Meier plotter 数据库评估关键基因的表达水平及其预后价值。使用 timer 算法确定 LUAD 组织中免疫细胞浸润与关键基因表达水平之间的相关性。此外,使用 maftools 包和 ggstatsplot 包在 R 软件中分别评估关键基因突变景观及其与肿瘤突变负担(TMB)评分的相关性分析。

结果

我们鉴定出 156 个常见的上调 DEG,基因本体论和途径富集分析表明,它们主要富集在有丝分裂细胞周期过程和细胞周期途径中。子网络中基因数量最多的 DEG 是 AURKB、CCNB2、CDC20、CDCA5、CDCA8、CENPF 和 KNTC1。七个关键基因在 LUAD 组织中高表达,并与预后不良相关。这些关键基因与大多数免疫细胞呈负相关。体细胞突变景观表明,AURKB、CDC20、CENPF 和 KNTC1 发生突变,并且与 TMB 评分呈正相关。

结论

我们的研究结果表明,七个关键基因的高表达与 LUAD 患者的预后不良相关。此外,TMB 评分表明,关键基因的高表达增加了肺腺癌患者的免疫细胞浸润,这可能显著提高免疫治疗的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/b2fdafe27b4e/12957_2022_2543_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/88dbf3bde2f3/12957_2022_2543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/0a607da8ffbc/12957_2022_2543_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/ef3c64a5feef/12957_2022_2543_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/adb5d06f7e69/12957_2022_2543_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/ec1cb2baaed2/12957_2022_2543_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/bda399c8d064/12957_2022_2543_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/b2fdafe27b4e/12957_2022_2543_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/88dbf3bde2f3/12957_2022_2543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/0a607da8ffbc/12957_2022_2543_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/ef3c64a5feef/12957_2022_2543_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/adb5d06f7e69/12957_2022_2543_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/ec1cb2baaed2/12957_2022_2543_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/bda399c8d064/12957_2022_2543_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/8966338/b2fdafe27b4e/12957_2022_2543_Fig7_HTML.jpg

相似文献

1
An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.肺腺癌患者预后和免疫浸润的综合分析,寻找潜在的生存指标的关键基因。
World J Surg Oncol. 2022 Mar 30;20(1):99. doi: 10.1186/s12957-022-02543-z.
2
High Expression of , , and Predicts Worse Prognosis among Nonsmoking Patients with Lung Adenocarcinoma through Bioinformatics Analysis.通过生物信息学分析, 、 、 在不吸烟肺腺癌患者中的高表达预示着更差的预后。
Biomed Res Int. 2020 Oct 20;2020:2071593. doi: 10.1155/2020/2071593. eCollection 2020.
3
Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.与肺腺癌相关的候选诊断和预后生物标志物的综合分析。
Med Sci Monit. 2020 Jun 24;26:e922070. doi: 10.12659/MSM.922070.
4
Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.肿瘤突变负荷与免疫浸润联合用于肺腺癌的预后评估。
Int Immunopharmacol. 2021 Sep;98:107807. doi: 10.1016/j.intimp.2021.107807. Epub 2021 Jun 25.
5
Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.全面分析 TPX2 相关 ceRNA 网络作为肺腺癌的预后生物标志物。
Int J Med Sci. 2020 Sep 1;17(16):2427-2439. doi: 10.7150/ijms.49053. eCollection 2020.
6
Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.基于GEO和TCGA数据库的肺腺癌预后相关基因分析
Medicine (Baltimore). 2020 May;99(19):e20183. doi: 10.1097/MD.0000000000020183.
7
Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma.HLF 表达降低预示肺腺癌患者预后不良。
Med Sci Monit. 2021 May 12;27:e929333. doi: 10.12659/MSM.929333.
8
Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.加权基因共表达网络分析鉴定出与KRAS突变型肺腺癌相关的枢纽基因。
Medicine (Baltimore). 2020 Aug 7;99(32):e21478. doi: 10.1097/MD.0000000000021478.
9
Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.基于 TCGA 和 GEO 数据库的 LUAD 潜在诊断和预后生物标志物的鉴定。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20204370.
10
Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.免疫相关基因在快速复发早期肺腺癌中表达谱的基因芯片分析。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2299-2310. doi: 10.1007/s00432-020-03287-7. Epub 2020 Jun 18.

引用本文的文献

1
Unraveling the oxidative stress landscape in diabetic foot ulcers: insights from bulk RNA and single-cell RNA sequencing data.解析糖尿病足溃疡中的氧化应激状况:来自 bulk RNA 和单细胞 RNA 测序数据的见解
Biol Direct. 2025 Jul 4;20(1):79. doi: 10.1186/s13062-025-00672-5.
2
Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity.血液系统恶性肿瘤中STING表达的生物信息学特征揭示了其与预后及抗肿瘤免疫的关联。
Front Immunol. 2025 Feb 5;16:1477100. doi: 10.3389/fimmu.2025.1477100. eCollection 2025.
3
Expression and role of FKBPL in lung adenocarcinoma.

本文引用的文献

1
Transmembrane p24 trafficking protein 2 regulates inflammation through the TLR4/NF-κB signaling pathway in lung adenocarcinoma.跨膜 p24 转运蛋白 2 通过 TLR4/NF-κB 信号通路在肺腺癌中调节炎症反应。
World J Surg Oncol. 2022 Feb 8;20(1):32. doi: 10.1186/s12957-021-02477-y.
2
The benefits and risks of pembrolizumab in combination with chemotherapy as first-line therapy in small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized control trials.帕博利珠单抗联合化疗作为小细胞肺癌一线治疗的获益与风险:非对照临床研究和随机对照试验的单臂汇总分析。
World J Surg Oncol. 2021 Oct 14;19(1):298. doi: 10.1186/s12957-021-02410-3.
3
FKBPL在肺腺癌中的表达及作用
J Cancer. 2024 Jan 1;15(1):166-175. doi: 10.7150/jca.87758. eCollection 2024.
4
KNTC1 and MCM2 are the molecular targets of gallbladder cancer.KNTC1 和 MCM2 是胆囊癌的分子靶点。
Aging (Albany NY). 2023 Jul 21;15(14):7008-7022. doi: 10.18632/aging.204889.
5
An integrated bioinformatics analysis of the S100 in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中S100的综合生物信息学分析。
Transl Cancer Res. 2023 Apr 28;12(4):717-731. doi: 10.21037/tcr-22-1353. Epub 2023 Apr 12.
6
Identification and Analysis of Necroptosis-Related Genes in COPD by Bioinformatics and Experimental Verification.通过生物信息学和实验验证鉴定和分析 COPD 中的坏死性凋亡相关基因。
Biomolecules. 2023 Mar 6;13(3):482. doi: 10.3390/biom13030482.
7
Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes.基于PRMT相关基因的肝细胞癌分子亚型分类
Front Pharmacol. 2023 Feb 22;14:1145408. doi: 10.3389/fphar.2023.1145408. eCollection 2023.
8
Integrated analysis identifies oxidative stress-related lncRNAs associated with progression and prognosis in colorectal cancer.综合分析鉴定出与结直肠癌进展和预后相关的氧化应激相关 lncRNAs。
BMC Bioinformatics. 2023 Mar 3;24(1):76. doi: 10.1186/s12859-023-05203-5.
9
Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma.鉴定与 TGF-β 信号相关的基因特征,用于预测肺腺癌的免疫治疗和靶向治疗。
World J Surg Oncol. 2022 Jun 6;20(1):183. doi: 10.1186/s12957-022-02595-1.
10
Ring finger protein 180 suppresses cell proliferation and energy metabolism of non-small cell lung cancer through downregulating C-myc.环指蛋白 180 通过下调 C-myc 抑制非小细胞肺癌细胞增殖和能量代谢。
World J Surg Oncol. 2022 May 21;20(1):162. doi: 10.1186/s12957-022-02599-x.
DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
DPYSL2 作为潜在的诊断和预后生物标志物与肺腺癌中的免疫浸润相关。
World J Surg Oncol. 2021 Sep 13;19(1):274. doi: 10.1186/s12957-021-02379-z.
4
Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13.从嘌呤能受体 P2Y13 的角度评估肺腺癌的肿瘤微环境免疫调节和预后
Bioengineered. 2021 Dec;12(1):6286-6304. doi: 10.1080/21655979.2021.1971029.
5
Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients.缺氧相关 lncRNA 特征的综合分析预测肺腺癌患者的预后和免疫微环境。
Bioengineered. 2021 Dec;12(1):6186-6200. doi: 10.1080/21655979.2021.1973874.
6
Effects of LncRNA MEG3 on immunity and autophagy of non-small cell lung carcinoma through IDO signaling pathway.长链非编码 RNA MEG3 通过 IDO 信号通路对非小细胞肺癌免疫和自噬的影响。
World J Surg Oncol. 2021 Aug 16;19(1):244. doi: 10.1186/s12957-021-02346-8.
7
Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells and .细胞周期蛋白 B2(CCNB2)刺激三阴性乳腺癌(TNBC)细胞的增殖。
Dis Markers. 2021 Jul 26;2021:5511041. doi: 10.1155/2021/5511041. eCollection 2021.
8
High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.肺鳞状细胞癌患者中CDK1和CDC20的高表达水平与较差的预后相关。
Front Mol Biosci. 2021 Jul 7;8:653805. doi: 10.3389/fmolb.2021.653805. eCollection 2021.
9
Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis.在 DNA 损伤反应 (DDR) 和肿瘤发生的队列中,有丝分裂综合征 Aurora 激酶 B (AURKB) 和有丝分裂缺陷 2 样 2 (MAD2L2)。
Mutat Res Rev Mutat Res. 2021 Jan-Jun;787:108376. doi: 10.1016/j.mrrev.2021.108376. Epub 2021 Apr 24.
10
miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.miR-133b 通过靶向 CDCA8 抑制肺腺癌细胞的增殖、迁移和侵袭。
Pathol Res Pract. 2021 Jul;223:153459. doi: 10.1016/j.prp.2021.153459. Epub 2021 Apr 28.